FDA Inspection
District 2-A1 Lions Eye Bank, IncDistrict 2-A1 Lions Eye Bank, Inc – FDA Inspection, Jun 18, 2018
Record Details
This FDA Inspection record concerns District 2-A1 Lions Eye Bank, Inc, with an inspection on June 18, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 47889b45-7694-4aa5-9c04-6f04892647ae
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1056012
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 1271.47(a)Testing, screening, donor eligibility procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of District 2-A1 Lions Eye Bank, Inc
3| Date | Classification | Office | Project area |
|---|---|---|---|
| July 18, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 21, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 16, 2011 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for District 2-A1 Lions Eye Bank, Inc
- FDA Inspection 1211484 - 2023-07-18
- FDA Inspection 845282 - 2013-08-21
- FDA Inspection 745427 - 2011-09-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.